GLA antibody (N-Term)
Quick Overview for GLA antibody (N-Term) (ABIN453055)
Target
See all GLA AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 90-120, N-Term
-
Specificity
- This antibody detects GLA at N-term.
-
Purification
- Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS
-
Immunogen
- KLH conjugated synthetic peptide between 90~120 amino acids from the N-terminal region of human GLA
-
-
-
-
Application Notes
-
Western blot: 1: 50 - 1: 100. ELISA: 1: 1,000.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) sodium azide as preservative
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store the antibody at 2 - 8 °C up to one month or (in aliquots) at -20 °C for longer.
-
-
- GLA (Galactosidase, alpha (GLA))
-
Alternative Name
- alpha-Galactosidase A
-
Background
- GLA is a homodimeric glycoprotein that hydrolyses the terminal alpha-galactosyl moieties from glycolipids and glycoproteins. This enzyme predominantly hydrolyzes ceramide trihexoside, and it can catalyze the hydrolysis of melibiose into galactose and glucose. A variety of mutations in this gene affect the synthesis, processing, and stability of this enzyme, which causes Fabry disease, a rare lysosomal storage disorder that results from a failure to catabolize alpha-D-galactosyl glycolipid moieties.Synonyms: Alpha-D-galactosidase A, Alpha-D-galactoside galactohydrolase, GLA, Melibiase
-
Molecular Weight
- 48767 Da
-
Gene ID
- 2717
-
NCBI Accession
- NP_000160
-
UniProt
- P06280
-
Pathways
- SARS-CoV-2 Protein Interactome
Target
-